Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Premature aging in serious mental illness
    Published on 2026-01-16
    6 months ago
  • Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats
    Published on 2026-01-16
    6 months ago
  • Oxytocin neurons in the anterior and posterior paraventricular nucleus have distinct behavioral functions and electrophysiological profiles
    Published on 2026-01-16
    6 months ago
  • Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia
    Published on 2026-01-16
    6 months ago
  • Neuromodulation and cognition in late-life depression
    Published on 2026-01-16
    6 months ago
  • Psychedelic therapeutics in psychiatric conditions
    Published on 2026-01-15
    6 months ago
  • Choreographing time: toward therapy-aligned entactogens for complex PTSD
    Published on 2026-01-15
    6 months ago
« Previous 1 … 25 26 27 28 29 … 143 Next »
Journal of Psychopharmacology
  • A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction
    Published on 2025-07-11
    1 year ago
  • Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics
    Published on 2025-07-11
    1 year ago
  • The effect of betahistine on weight-related and metabolic measures in patients with schizophrenia treated with olanzapine and risperidone
    Published on 2025-07-08
    1 year ago
  • Evaluating the impact of cannabis oil for autistic children with and without concomitant medications: Insights from an open-label study
    Published on 2025-07-04
    1 year ago
  • Roles of the 5-HT1A receptor in zebrafish responses to potential threat and in sociality
    Published on 2025-07-01
    1 year ago
  • Deaths related to the use of diarylethylamines, with a focus on the United Kingdom: A systematic review and case series report
    Published on 2025-07-01
    1 year ago
  • Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression
    Published on 2025-07-01
    1 year ago
« Previous 1 … 25 26 27 28 29 … 150 Next »
European Neuropsychopharmacology
  • Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials
    Published on 2025-05-23
    1 year ago
  • Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003–2018
    Published on 2025-05-23
    1 year ago
  • Functioning Assessment Short Test (FAST): validity and reliability in adolescent and young adults with Borderline Personality Disorder (BPD)
    Published on 2025-05-23
    1 year ago
  • Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
    Published on 2025-05-23
    1 year ago
  • Attention to the quality of methods is critical for valuable research: some examples relevant for animal models of psychiatric disorders
    Published on 2025-05-23
    1 year ago
  • Thinner and wiser? Prospects of GLP-1 agonists in psychiatry
    Published on 2025-05-23
    1 year ago
  • Targeting hallucinations in schizophrenia: Improving research translation into clinical practice
    Published on 2025-05-23
    1 year ago
« Previous 1 … 25 26 27 28 29 … 168 Next »

   Pharma Pub